[Ip-health] Upcoming webinar: Fair pricing of medicines: what lessons from growing transparency in vaccines prices?

Marcela Vieira marcelacfvieira at gmail.com
Thu Feb 13 02:28:13 PST 2020

Dear ip-health readers,

We would like to invite you to the next webinar of the series organized by
the Knowledge Network for Innovation and Access to Medicines, a project of
the Global Health Centre at the Graduate Institute of Geneva, which will
take place on February 27, 4-5 pm CET.
We hope you will be able to join us for this discussion. The webinar will
be recorded and made available a few days after it takes place. A list of
the previous webinars of the series and their recordings and related
materials is available at: *https://www.knowledgeportalia.org/webinars


*Fair pricing of medicines: what lessons from growing transparency in
vaccines prices?*

Thursday, February 27, 4pm - 5pm CET
To join the webinar, please register here:

Suerie Moon, Co-director, Global Health Centre, Graduate Institute of Geneva
Tania Cernuschi, Programme Manager, Department of Immunization, Vaccines
and Biologicals, World Health Organization

Moon Suerie, Mariat Stephanie, Kamae Isao, Pedersen Hanne Bak. Defining the
concept of fair pricing for medicines BMJ 2020; 368 :l4726,
Cernuschi Tania, Gilchrist Shawn, Hajizada Adnan, Malhame Melissa, Mariat
Stephanie, Widmyer Greg et al. Price transparency is a step towards
sustainable access in middle income countries BMJ 2020; 368 :l5375,

The fairness of medicines prices remains an issue of widespread global
concern. Equitable access to medicines and financially-sustainable health
systems are in the public interest, as is ensuring adequate investment in
innovation. However, further debate is needed on: What is the concept of a
fair price? How fair is any particular price for a specific medicine in a
specific country? And how can more fairness be achieved in practice? The
British Medical Journal (BMJ) recently published a series of papers,
commissioned by the World Health Organization, on different aspects of fair
pricing (https://www.bmj.com/fair-pricing), two of which will be presented
in this webinar:

Suerie Moon will present a framework for assessing the fairness of prices,
taking into account both buyers’ and sellers’ considerations. Combining
several factors including affordability, supply security, research and
development (R&D) costs, and fair profit, Moon and colleagues developed the
concept of a “fair pricing zone”, taking into account the need for both
innovation and access across high, medium and low-resource contexts. Tania
Cernuschi will then present how the WHO Market Information for Access to
Vaccines (MI4A) project increased the transparency of vaccines prices, and
how the resulting information improved understanding of the global vaccines
market and informed country practices in price negotiations and procurement.

The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event. Recordings of all webinars will be made available at the Knowledge
Portal on Innovation and Access to Medicines. After registering, you will
receive a confirmation email with additional information on how to join the
webinar using the Zoom platform.

Related materials by the Knowledge Network on Innovation and Access to
Medicines, available at https://www.knowledgeportalia.org/:

Research syntheses: Affordability; Price controls/regulations; Health
Technology Assessment; Tiered pricing; Competition Law; Costs of
pharmaceutical R&D
Previous webinars:
Addressing high drug prices - what can be learned from European policies?
Presented by Sabine Vogler, Austrian Public Health Institute (GÖG);
Using competition law to address high medicines prices, presented by Fred
Abbott, Florida State University College of Law;
Regulating drug prices: national and global implications of Canada’s recent
reforms, presented by Elena Lungu, Manager of Policy Development, Canada’s
Patented Medicine Prices Review Board (PMPRB)

Marcela Vieira
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines

Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira at graduateinstitute.ch

More information about the Ip-health mailing list